Johnny_Three_Sixteen
Posted - 40 minutes ago
$CMRX Australia news due anytime now.
JDRStuart
Posted - 3 days ago
$CMRX From the one to watch on KZIA board
JDRStuart
Posted - 3 days ago
$CMRX
lyn30
Posted - 3 days ago
$CMRX Can u pls tell me if this has has option to short? No worries I will check 😂
ARDX_Bull
Posted - 6 days ago
$CMRX Waiting is boring but the only game of the town! On November 14, 2024 - Vestal Point Capital, LP filed a 13F-HR form disclosing ownership of 1,400,000 shares of Chimerix valued at $1,302,000 USD as of September 30, 2024. The entity filed a previous 13F-HR on August 14, 2024 disclosing 1,400,000 shares of Chimerix Bridgeway Capital Management Inc filed a 13F-HR form disclosing ownership of 1,065,914 shares of Chimerix valued at $991,300 USD as of September 30, 2024. The entity filed a previous 13F-HR on August 14, 2024 disclosing 1,080,914 shares of Chimerix, Inc.. This represents a change in shares of -1.39% during the quarter. Adage Capital Partners Gp, L.l.c. filed a 13F-HR form disclosing ownership of 600,000 shares of Chimerix, Inc. (US:CMRX) valued at $558,000 USD as of September 30, 2024. The entity filed a previous 13F-HR on August 14, 2024 disclosing 600,000 shares
ARDX_Bull
Posted - 6 days ago
$CMRX The management team said they’re “monitoring the listing compliance situation…” all talk no action. On November 14, 2024 - Millennium Management Llc filed a 13F-HR form disclosing ownership of 2,395,735 shares of Chimerix, Inc. (US:CMRX) valued at $2,228,034 USD as of September 30, 2024. The entity filed a previous 13F-HR on August 14, 2024 disclosing 1,021,305 shares of Chimerix, Inc.. This represents a change in shares of 134.58% during the quarter. On November 14, 2024 - Armistice Capital, Llc filed a 13F-HR form disclosing ownership of 2,208,000 shares of Chimerix, Inc. (US:CMRX) valued at $2,053,440 USD as of September 30, 2024. The entity filed a previous 13F-HR on August 14, 2024 disclosing 2,224,000 shares of Chimerix, Inc.. This represents a change in shares of -0.72% during the quarter.
Onatarty
Posted - 1 week ago
$CMRX $ALRN 🚨💥🚀🔥 PR is incoming. $BOLT.CN $.31 (+19.23%) average volume increased ~100%. I'm going to add on Monday if it's still this low. Latest News 🚀🤑 Market cap at $5.7M; Whiting’s influence may drive upward movement if new partnerships or exploration progress 1️⃣ Bolt Metals ($BOLT.CN) advances with two key updates: Ben Whiting joins as Technical Advisor, and a C$544,500 private placement closed 💸. 2️⃣ Funding: The placement includes shares and warrants, exercisable at C$0.75 for two years, with proceeds for exploration, working capital, and copper project growth ⚒️
ARDX_Bull
Posted - 1 week ago
$CMRX New owner On November 13, 2024 - BlackRock, Inc. filed a 13F-HR form disclosing ownership of 815,992 shares of Chimerix, Inc. (US:CMRX) valued at $758,873 USD as of September 30, 2024. And On November 12, 2024 - Acadian Asset Management Llc filed a 13F-HR form disclosing ownership of 2,188,482 shares of Chimerix, Inc. (US:CMRX) valued at $2,035,288 USD as of September 30, 2024. The entity filed a previous 13F-HR on August 6, 2024 disclosing 2,174,813 shares of Chimerix, Inc..
ARDX_Bull
Posted - 1 week ago
$CMRX On November 12, 2024 - Geode Capital Management, Llc filed a 13F-HR form disclosing ownership of 846,249 shares of Chimerix, Inc. (US:CMRX) valued at $787,012 USD as of September 30, 2024. The entity filed a previous 13F-HR on August 9, 2024 disclosing 885,824 shares of Chimerix, Inc.. This represents a change in shares of -4.47% during the quarter.
SweSapiens
Posted - 1 week ago
$CMRX The rocket is getting ready for launch?
justiceforb_85
Posted - 1 week ago
$CMRX strong data for dordaviprone for H3 K27M-mutant DMG. I think the phase 3 will be successful, which will be amazing for the patients who have limited treatment options.
CAD_CAM
Posted - 1 week ago
$CMRX Chimerix’s Phase 2 Reassessment Boosts Buy Rating Amid Promising Data and Strong Financials
Bigdubs
Posted - 1 week ago
$CMRX sold at 1.04… I’ll be back, thanks for a nice gain.
ocatraps
Posted - 1 week ago
$CMRX yesterday’s conference call was embarrassing to say the least. It lasted 12 minutes, no analysts interested and just one silly question they were not even able to give a convincing answer to.
ocatraps
Posted - 1 week ago
$CMRX this company is a joke and it’s been played accordingly. It could go even up to 2 dollars intraday but at the end of the trading day will still be below 1. Delisting coming.
ARDX_Bull
Posted - 1 week ago
$CMRX Mentioned this IDMC last year that was repeated both by Mike on ER and Ed White on his analytical theories for a Buy $11 PT yesterday. Now back to 2014 GSK sponsoring a ph3 trial was called off early by IDMC and patients who were on placebo unmasked and receiving all drug treatment personally i never believed it’s even fair for children to have placebo in our Ph3 Action trial. it’s inhumane. https://cancerletter.com/clinical/20140731_2/
Big_Dzick
Posted - 1 week ago
$CMRX will go up to 2
jiggs10
Posted - 1 week ago
$CMRX I think there will be some bio Buyouts over the long weekend
jiggs10
Posted - 1 week ago
$CMRX They have a pretty good drug n tons of cash. Their obviously on the chopping block at $6 to $10
ARDX_Bull
Posted - 1 week ago
$CMRX Big holder is still here On November 7, 2024 - Monaco Asset Management SAM filed a 13F-HR form disclosing ownership of 4,221,574 shares of Chimerix, Inc. (US:CMRX) valued at $3,926,064 USD as of September 30, 2024. The entity filed a previous 13F-HR on August 7, 2024 disclosing 4,377,674 shares of Chimerix, Inc.. This represents a change in shares of -3.57% during the quarter. So as this smaller one On November 6, 2024 - Acuitas Investments, LLC filed a 13F-HR form disclosing ownership of 796,401 shares of Chimerix, Inc. (US:CMRX) valued at $740,653 USD as of September 30, 2024. The entity filed a previous 13F-HR on August 5, 2024 disclosing 638,657 shares of Chimerix, Inc.. This represents a change in shares of 24.70% during the quarter.
ARDX_Bull
Posted - 1 week ago
$CMRX Edward White has given his Buy rating price at $11 due to a combination of factors surrounding Chimerix’s ongoing developments and financial health. .... Chimerix’s Phase 3 ACTION study, which involves the drug dordaviprone for treating H3 K27M-mutant glioma, has been progressing positively. The Independent Data Monitoring Committee has recommended the continuation of the study following a safety review. This study is significant as dordaviprone has FDA Fast Track and Rare Pediatric Disease Designations, highlighting its potential importance in treating high-grade glioma. The expectation of interim overall survival data in the third quarter of 2025 and the potential for accelerated FDA approval based on progression-free survival data further support the Buy rating, as these developments could lead to a successful drug launch by late 2026.
ocatraps
Posted - 1 week ago
$CMRX what a surprise, everything is up and this pos is tanking….
lecorb
Posted - 2 weeks ago
$CMRX Chimerix GAAP EPS of -$0.26 misses by $0.02, revenue of $0.02M misses by $0.29M
Estimize
Posted - 2 weeks ago
$CMRX reported - EPS and - revenue for Q3.
http://www.estimize.com/intro/cmrx?chart=historical&metric_name=eps&utm_content=CMRX&utm_medium=
SomePoorGuy
Posted - 2 weeks ago
$CMRX Quarterly Financials won't mean much, but a solid update on the ONC206 dose escalation study would be great.
rexston
Posted - 2 weeks ago
$CMRX why drop 10%?
Bartos1976
Posted - 2 weeks ago
$CMRX letting this one ride for the long haul
ManfredMustermann
Posted - 2 weeks ago
$CMRX up by small volume
MCC2ZAP
Posted - 2 weeks ago
$CMRX UK detects two more cases of MPOX variant.